
Brian J. Gangle
Examiner (ID: 511, Phone: (571)272-1181 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 1233 |
| Issued Applications | 798 |
| Pending Applications | 132 |
| Abandoned Applications | 327 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19134536
[patent_doc_number] => 11969445
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
[patent_app_type] => utility
[patent_app_number] => 18/232980
[patent_app_country] => US
[patent_app_date] => 2023-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 23531
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18232980
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/232980 | Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH | Aug 10, 2023 | Issued |
Array
(
[id] => 19650030
[patent_doc_number] => 12171790
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Microorganisms engineered to reduce hyperphenylalaninemia
[patent_app_type] => utility
[patent_app_number] => 18/446970
[patent_app_country] => US
[patent_app_date] => 2023-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 23580
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18446970
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/446970 | Microorganisms engineered to reduce hyperphenylalaninemia | Aug 8, 2023 | Issued |
Array
(
[id] => 19280022
[patent_doc_number] => 20240216495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE
[patent_app_type] => utility
[patent_app_number] => 18/446883
[patent_app_country] => US
[patent_app_date] => 2023-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49704
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18446883
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/446883 | COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE | Aug 8, 2023 | Pending |
Array
(
[id] => 18902699
[patent_doc_number] => 20240018184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => Method of Cleaning and/or Sanitizing a Separation Matrix
[patent_app_type] => utility
[patent_app_number] => 18/354413
[patent_app_country] => US
[patent_app_date] => 2023-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18354413
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/354413 | Method of Cleaning and/or Sanitizing a Separation Matrix | Jul 17, 2023 | Pending |
Array
(
[id] => 18724304
[patent_doc_number] => 20230338438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => BACTERIAL BIOFILMS AND CANCER
[patent_app_type] => utility
[patent_app_number] => 18/217857
[patent_app_country] => US
[patent_app_date] => 2023-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20348
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18217857
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/217857 | BACTERIAL BIOFILMS AND CANCER | Jul 2, 2023 | Pending |
Array
(
[id] => 19921739
[patent_doc_number] => 12295998
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => Enhancing immunogenicity of
[patent_app_type] => utility
[patent_app_number] => 18/339723
[patent_app_country] => US
[patent_app_date] => 2023-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14385
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18339723
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/339723 | Enhancing immunogenicity of | Jun 21, 2023 | Issued |
Array
(
[id] => 18737954
[patent_doc_number] => 20230346856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => Bifidobacterium brevis and its application in preventing or alleviating psoriasis thereof
[patent_app_type] => utility
[patent_app_number] => 18/212253
[patent_app_country] => US
[patent_app_date] => 2023-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18212253
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/212253 | Bifidobacterium brevis and its application in preventing or alleviating psoriasis thereof | Jun 20, 2023 | Issued |
Array
(
[id] => 19265370
[patent_doc_number] => 20240209069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => COMPOSITION FOR THE TREATMENT OF ANTIBODY DEFICIENCIES
[patent_app_type] => utility
[patent_app_number] => 18/337354
[patent_app_country] => US
[patent_app_date] => 2023-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18337354
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/337354 | Composition for the treatment of antibody deficiencies | Jun 18, 2023 | Issued |
Array
(
[id] => 20315207
[patent_doc_number] => 12453746
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Use of akkermansia muciniphila in preparation of pharmaceutical composition or health care product composition for improving metabolic syndrome
[patent_app_type] => utility
[patent_app_number] => 18/871201
[patent_app_country] => US
[patent_app_date] => 2023-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 14143
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18871201
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/871201 | Use of akkermansia muciniphila in preparation of pharmaceutical composition or health care product composition for improving metabolic syndrome | Jun 7, 2023 | Issued |
Array
(
[id] => 20127947
[patent_doc_number] => 12370247
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-29
[patent_title] => Multivalent pneumococcal vaccines
[patent_app_type] => utility
[patent_app_number] => 18/202842
[patent_app_country] => US
[patent_app_date] => 2023-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 27
[patent_no_of_words] => 105627
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 726
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18202842
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/202842 | Multivalent pneumococcal vaccines | May 25, 2023 | Issued |
Array
(
[id] => 19667729
[patent_doc_number] => 12180462
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-31
[patent_title] => Global gene regulators (GGR) as vaccine candidates against paratuberculosis
[patent_app_type] => utility
[patent_app_number] => 18/320834
[patent_app_country] => US
[patent_app_date] => 2023-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 28
[patent_no_of_words] => 26523
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18320834
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/320834 | Global gene regulators (GGR) as vaccine candidates against paratuberculosis | May 18, 2023 | Issued |
Array
(
[id] => 19201468
[patent_doc_number] => 20240173367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING CHOLESTATIC DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/319086
[patent_app_country] => US
[patent_app_date] => 2023-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22486
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18319086
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/319086 | COMPOSITIONS AND METHODS FOR TREATING CHOLESTATIC DISEASE | May 16, 2023 | Abandoned |
Array
(
[id] => 19089721
[patent_doc_number] => 11951140
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => Modulation of an individual's gut microbiome to address osteoporosis and bone disease
[patent_app_type] => utility
[patent_app_number] => 18/143399
[patent_app_country] => US
[patent_app_date] => 2023-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 16855
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18143399
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/143399 | Modulation of an individual's gut microbiome to address osteoporosis and bone disease | May 3, 2023 | Issued |
Array
(
[id] => 18860250
[patent_doc_number] => 20230414684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => COMPOSITION FOR PREVENTING OR TREATING COLORECTAL CANCER COMPRISING MIXED STRAIN OF PROBIOTICS
[patent_app_type] => utility
[patent_app_number] => 18/311691
[patent_app_country] => US
[patent_app_date] => 2023-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6116
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18311691
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/311691 | COMPOSITION FOR PREVENTING OR TREATING COLORECTAL CANCER COMPRISING MIXED STRAIN OF PROBIOTICS | May 2, 2023 | Pending |
Array
(
[id] => 19554963
[patent_doc_number] => 20240366755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => METHODS OF USE & COMPOSITIONS OF IBD, IBS, & ANTINEOPLASTICMICROBIAL THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 18/310525
[patent_app_country] => US
[patent_app_date] => 2023-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6384
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18310525
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/310525 | METHODS OF USE & COMPOSITIONS OF IBD, IBS, & ANTINEOPLASTICMICROBIAL THERAPEUTICS | Apr 30, 2023 | Pending |
Array
(
[id] => 19808404
[patent_doc_number] => 12239763
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-04
[patent_title] => Peptides and antibodies for the removal of biofilms
[patent_app_type] => utility
[patent_app_number] => 18/141270
[patent_app_country] => US
[patent_app_date] => 2023-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 42
[patent_no_of_words] => 49755
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18141270
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/141270 | Peptides and antibodies for the removal of biofilms | Apr 27, 2023 | Issued |
Array
(
[id] => 18769450
[patent_doc_number] => 20230364214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => Novel Polysaccharide and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 18/305948
[patent_app_country] => US
[patent_app_date] => 2023-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44620
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18305948
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/305948 | Polysaccharide and uses thereof | Apr 23, 2023 | Issued |
Array
(
[id] => 18877491
[patent_doc_number] => 20240000860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => METHODS FOR TREATING AUTISM SPECTRUM DISORDER
[patent_app_type] => utility
[patent_app_number] => 18/302656
[patent_app_country] => US
[patent_app_date] => 2023-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17799
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18302656
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/302656 | METHODS FOR TREATING AUTISM SPECTRUM DISORDER | Apr 17, 2023 | Pending |
Array
(
[id] => 18806915
[patent_doc_number] => 20230381248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => METHOD FOR TREATING AND/OR PREVENTING ATOPY AND ALLERGIC DISEASES BY USING BACTERIA OR COMPOSITIONS HAVING 7 ALPHA-DEHYDROXYLASE ACTIVITY, AND/OR BILE ACID RECEPTORS FXR AND/OR TGR5 AGONISTS
[patent_app_type] => utility
[patent_app_number] => 18/135394
[patent_app_country] => US
[patent_app_date] => 2023-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18135394
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/135394 | METHOD FOR TREATING AND/OR PREVENTING ATOPY AND ALLERGIC DISEASES BY USING BACTERIA OR COMPOSITIONS HAVING 7 ALPHA-DEHYDROXYLASE ACTIVITY, AND/OR BILE ACID RECEPTORS FXR AND/OR TGR5 AGONISTS | Apr 16, 2023 | Pending |
Array
(
[id] => 18536042
[patent_doc_number] => 20230241129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => Probiotic to Enhance an Individual's Skin Microbiome
[patent_app_type] => utility
[patent_app_number] => 18/130946
[patent_app_country] => US
[patent_app_date] => 2023-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18130946
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/130946 | Probiotic to enhance an individual's skin microbiome | Apr 4, 2023 | Issued |